Amyloid beta-protein and neural network dysfunction

Journal of Neurodegenerative Diseases

Volumn , Issue , 2013, Pages

  Peña Ortega, Fernando ^a  

^a INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; CELL POPULATION; COGNITIVE DEFECT; ELECTROENCEPHALOGRAPHY; GAMMA RHYTHM; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL; NERVE CELL NETWORK; NONHUMAN; OSCILLATION; REVIEW; THETA RHYTHM;

EID: 84884666415     PISSN: 2090858X     EISSN: 20908601     Source Type: Journal    
DOI: 10.1155/2013/657470     Document Type: Review

References (83)

1. Selkoe D. J., Alzheimer's disease is a synaptic failure. Science 2002 298 5594 789 791 2-s2.0-0037174618 10.1126/science.1074069 (Pubitemid 35231524)
2. Walsh D. M., Selkoe D. J., A β oligomers: a decade of discovery. Journal of Neurochemistry 2007 101 5 1172 1184 2-s2.0-34248190279 10.1111/j.1471-4159.2006.04426.x (Pubitemid 46718812)
3. Lue L. F., Kuo Y. M., Roher A. E., Brachova L., Shen Y., Sue L., Beach T., Kurth J. H., Rydel R. E., Rogers J., Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease. American Journal of Pathology 1999 155 3 853 862 2-s2.0-0032888131 (Pubitemid 29426831)
4. Näslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Greengard P., Buxbaum J. D., Correlation between elevated levels of amyloid β -peptide in the brain and cognitive decline. Journal of the American Medical Association 2000 283 12 1571 1577 2-s2.0-0038117796 (Pubitemid 30161512)
5. Benilova I., Karran E., De Strooper B., The toxic A β oligomer and Alzheimer's disease: an emperor in need of clothes. Nature Neuroscience 2012 15 3 349 357
6. Sheng M., Sabatini B. L., Südhof T. C., Synapses and Alzheimer's disease. Cold Spring Harbor Perspectives in Biology 2012 4 5
7. Corbett A., Smith J., Ballard C., New and emerging treatments for Alzheimer's disease. Expert Review of Neurotherapeutics 2012 12 5 535 543
8. Palop J. J., Mucke L., Amyloid- β -induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nature Neuroscience 2010 13 7 812 818 2-s2.0-77954132249 10.1038/nn.2583
9. Wesson D. W., Nixon R. A., Levy E., Wilson D. A., Mechanisms of neural and behavioral dysfunction in Alzheimer's disease. Molecular Neurobiology 2011 43 3 163 179 2-s2.0-79958253107 10.1007/s12035-011-8177-1
10. Peña F., Gutiérrez-Lerma A. I., Quiroz-Baez R., Arias C., The role of β -amyloid protein in synaptic function: implications for Alzheimer's disease therapy. Current Neuropharmacology 2006 4 2 149 163 2-s2.0-33646570823 10.2174/157015906776359531
11. Faught E., Antiepileptic drug trials, the view from the clinic. Epileptic Disorders 2012 14 2 114 123
12. Rombouts S. A. R. B., Goekoop R., Stam C. J., Barkhof F., Scheltens P., Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease. NeuroImage 2005 26 4 1078 1085 2-s2.0-20444369540 10.1016/j.neuroimage. 2005.03.022 (Pubitemid 40806486)
13. Prvulovic D., van de Ven V., Sack A. T., Maurer K., Linden D. E. J., Functional activation imaging in aging and dementia. Psychiatry Research 2005 140 2 97 113 2-s2.0-27544442936 10.1016/j.pscychresns.2005.06.006 (Pubitemid 41540423)
14. Platt B., Drever B., Koss D., Stoppelkamp S., Jyoti A., Plano A., Utan A., Merrick G., Ryan D., Melis V., Wan H., Mingarelli M., Porcu E., Scrocchi L., Welch A., Riedel G., Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1. PLoS ONE 2011 6 11 e27068
15. Small D. H., Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression? Trends in Molecular Medicine 2008 14 3 103 108 2-s2.0-40649095625 10.1016/j.molmed.2007.12.006
16. Cleary J. P., Walsh D. M., Hofmeister J. J., Shankar G. M., Kuskowski M. A., Selkoe D. J., Ashe K. H., Natural oligomers of the amyloid- β protein specifically disrupt cognitive function. Nature Neuroscience 2005 8 1 79 84 2-s2.0-16644379264 10.1038/nn1372 (Pubitemid 41236735)
17. Lesné S., Ming T. K., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gallagher M., Ashe K. H., A specific amyloid- β protein assembly in the brain impairs memory. Nature 2006 440 7082 352 357 2-s2.0-33645038471 10.1038/nature04533
18. Balducci C., Beeg M., Stravalaci M., Bastone A., Sclip A., Biasini E., Tapella L., Colombo L., Manzoni C., Borsello T., Chiesa R., Gobbi M., Salmona M., Forloni G., Synthetic amyloid- β oligomers impair long-term memory independently of cellular prion protein. Proceedings of the National Academy of Sciences of the United States of America 2010 107 5 2295 2300 2-s2.0-76649093635 10.1073/pnas.0911829107
19. Kittelberger K. A., Piazza F., Tesco G., Reijmers L. G., Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice. PLoS ONE 2012 7 1 e29940
20. Mugantseva E. A., Podolski I. Y., Animal model of Alzheimer's disease: characteristics of EEG and memory. Central European Journal of Biology 2009 4 4 507 514 2-s2.0-76149104899 10.2478/s11535-009-0054-9
21. Villette V., Poindessous-Jazat F., Simon A., Léna C., Roullot E., Bellessort B., Epelbaum J., Dutar P., Stéphan A., Decreased rhythmic GABAergic septal activity and memory-associated θ oscillations after hippocampal amyloid- β pathology in the rat. Journal of Neuroscience 2010 30 33 10991 11003 2-s2.0-77955860261 10.1523/JNEUROSCI.6284-09.2010
22. Villette V., Poindessous-Jazat F., Bellessort B., Roullot E., Peterschmitt Y., Epelbaum J., Stéphan A., Dutar P., A new neuronal target for beta-amyloid peptide in the rat hippocampus. Neurobiology of Aging 2012 33 6 1 14
23. Traub R. D., Spruston N., Soltesz I., Konnerth A., Whittington M. A., Jefferys J. G. R., Gamma-frequency oscillations: a neuronal population phenomenon, regulated by synaptic and intrinsic cellular processes, and inducing synaptic plasticity. Progress in Neurobiology 1998 55 6 563 575 2-s2.0-0032144795 10.1016/S0301-0082(98)00020-3 (Pubitemid 28293581)
24. Buzsáki G., Theta oscillations in the hippocampus. Neuron 2002 33 3 325 340 2-s2.0-0037204104 10.1016/S0896-6273(02)00586-X (Pubitemid 34158839)
25. Klausberger T., Somogyi P., Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 2008 321 5885 53 57 2-s2.0-46849083268 10.1126/science.1149381 (Pubitemid 351956237)
26. Ramirez J. M., Tryba A. K., Peña F., Pacemaker neurons and neuronal networks: an integrative view. Current Opinion in Neurobiology 2004 14 6 665 674 2-s2.0-9644294519 10.1016/j.conb.2004.10.011 (Pubitemid 39576196)
27. Sun M. K., Alkon D. L., Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by β -amyloid 25-35. Journal of Neurophysiology 2002 87 5 2441 2449 2-s2.0-0036082750 (Pubitemid 34670715)
28. Driver J. E., Racca C., Cunningham M. O., Towers S. K., Davies C. H., Whittington M. A., LeBeau F. E. N., Impairment of hippocampal gamma (γ)-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP). European Journal of Neuroscience 2007 26 5 1280 1288 2-s2.0-34548321410 10.1111/j.1460-9568.2007.05705.x (Pubitemid 47346751)
29. Cacucci F., Yi M., Wills T. J., Chapman P., O'Keefe J., Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model. Proceedings of the National Academy of Sciences of the United States of America 2008 105 22 7863 7868 2-s2.0-45549087725 10.1073/pnas. 0802908105 (Pubitemid 351872729)
30. Busche M. A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K. H., Haass C., Staufenbiel M., Konnerth A., Garaschuk O., Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008 321 5896 1686 1689 2-s2.0-52249115856 10.1126/science.1162844
31. Busche M. A., Chen X., Henning H. A., Reichwald J., Staufenbiel M., Sakmann B., Konnerth A., Critical role of soluble amyloid- β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2012 109 22 8740 8745
32. Minkeviciene R., Rheims S., Dobszay M. B., Zilberter M., Hartikainen J., Fülöp L., Penke B., Zilberter Y., Harkany T., Pitkänen A., Tanila H., Amyloid β -induced neuronal hyperexcitability triggers progressive epilepsy. Journal of Neuroscience 2009 29 11 3453 3462 2-s2.0-63849180498 10.1523/JNEUROSCI.5215-08.2009
33. Wang Y., Zhang G., Zhou H., Barakat A., Querfurth H., Opposite effects of low and high doses of A β 42 on electrical network and neuronal excitability in the rat prefrontal cortex. PLoS ONE 2009 4 12 2-s2.0-77549084548 10.1371/journal.pone.0008366 e8366
34. Peña F., Ordaz B., Balleza-Tapia H., Bernal-Pedraza R., Márquez-Ramos A., Carmona-Aparicio L., Giordano M., Beta-amyloid protein (25-35) disrupts hippocampal network activity: role of Fyn-kinase. Hippocampus 2010 20 1 78 96 2-s2.0-75149170925 10.1002/hipo.20592
35. Colom L. V., Castañeda M. T., Bañuelos C., Puras G., García-Hernández A., Hernandez S., Mounsey S., Benavidez J., Lehker C., Medial septal β -amyloid 1-40 injections alter septo-hippocampal anatomy and function. Neurobiology of Aging 2010 31 1 46 57 2-s2.0-70449524669 10.1016/j.neurobiolaging.2008.05.006
36. Peña-Ortega F., Bernal-Pedraza R., Amyloid beta peptide slows down sensory-induced hippocampal oscillations. International Journal of Peptides 2012 2012 8 236289
37. Uhlhaas P. J., Singer W., Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006 52 1 155 168 2-s2.0-33749081115 10.1016/j.neuron.2006.09.020 (Pubitemid 44466360)
38. Bagheri M., Joghataei M. T., Mohseni S., Roghani M., Genistein ameliorates learning and memory deficits in amyloid β (1-40) rat model of Alzheimer's disease. Neurobiology of Learning and Memory 2011 95 3 270 276 2-s2.0-79952622790 10.1016/j.nlm.2010.12.001
39. Nobakht M., Hoseini S. M., Mortazavi P., Sohrabi I., Esmailzade B., Rahbar Rooshandel N., Omidzahir S., Neuropathological changes in brain cortex and hippocampus in a rat model of Alzheimer's disease. Iran Biomedical Journal 2011 15 1 51 58
40. Lega B. C., Jacobs J., Kahana M., Human hippocampal theta oscillations and the formation of episodic memories. Hippocampus 2012 22 4 748 761
41. Sohal V. S., Zhang F., Yizhar O., Deisseroth K., Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009 459 7247 698 702 2-s2.0-66649110345 10.1038/nature07991
42. Kowalski J. W., Gawel M., Pfeffer A., Barcikowska M., The diagnostic value of EEG in Alzheimer disease: correlation with the severity of mental impairment. Journal of Clinical Neurophysiology 2001 18 6 570 575 2-s2.0-0035667389 (Pubitemid 34027853)
43. Schreiter-Gasser U., Gasser T., Ziegler P., Quantitative EEG analysis in early onset Alzheimer's disease: correlations with severity, clinical characteristics, visual EEG and CCT. Electroencephalography and Clinical Neurophysiology 1994 90 4 267 272 2-s2.0-0028217198 10.1016/0013-4694(94)90144-9 (Pubitemid 24118519)
44. Nobili F., Copello F., Vitali P., Prastaro T., Carozzo S., Perego G., Rodriguez G., Timing of disease progression by quantitative EEG in Alzheimer's patients. Journal of Clinical Neurophysiology 1999 16 6 566 573 2-s2.0-0032748821
45. Ihl R., Dierks T., Martin E. M., Frölich L., Maurer K., Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biological Psychiatry 1996 39 5 319 325 2-s2.0-0029930305 10.1016/0006-3223(95)00174-3 (Pubitemid 26122558)
46. Babiloni C., Frisoni G. B., Pievani M., Vecchio F., Lizio R., Buttiglione M., Geroldi C., Fracassi C., Eusebi F., Ferri R., Rossini P. M., Hippocampal volume and cortical sources of EEG alpha rhythms in mild cognitive impairment and Alzheimer disease. NeuroImage 2009 44 1 123 135 2-s2.0-55349117078 10.1016/j.neuroimage.2008.08.005
47. Harris K. D., Csicsvari J., Hirase H., Dragoi G., Buzsáki G., Organization of cell assemblies in the hippocampus. Nature 2003 424 6948 552 556 2-s2.0-0043069766 10.1038/nature01834 (Pubitemid 36975776)
48. Wang J., Ikonen S., Gurevicius K., van Groen T., Tanila H., Alteration of cortical EEG in mice carrying mutated human APP transgene. Brain Research 2002 943 2 181 190 2-s2.0-0037067796 10.1016/S0006-8993(02)02617-3 (Pubitemid 36120378)
49. Jyoti A., Plano A., Riedel G., Platt B., EEG, activity, and sleep architecture in a transgenic A β PP swe/PSEN1A246E Alzheimer's disease mouse. Journal of Alzheimer's Disease 2010 22 3 873 887 2-s2.0-78650644126 10.3233/JAD-2010-100879
50. Scott L., Feng J., Kiss T., Needle E., Atchison K., Kawabe T. T., Milici A. J., Hajós-Korcsok E., Riddell D., Hajós M., Age-dependent disruption in hippocampal theta oscillation in amyloid- β overproducing transgenic mice. Neurobiology of Aging 2012 33 7 13 23
51. Balleza-Tapia H., Huanosta-Gutiérrez A., Márquez-Ramos A., Arias N., Peña F., Amyloid β oligomers decrease hippocampal spontaneous network activity in an age-dependent manner. Current Alzheimer Research 2010 7 5 453 462 2-s2.0-78549243744 10.2174/156720510791383859
52. Cummins T. D. R., Broughton M., Finnigan S., Theta oscillations are affected by amnestic mild cognitive impairment and cognitive load. International Journal of Psychophysiology 2008 70 1 75 81 2-s2.0-51249114963 10.1016/j.ijpsycho.2008.06.002
53. Adaya-Villanueva A., Ordaz B., Balleza-Tapia H., Márquez-Ramos A., Peña-Ortega F., Beta-like hippocampal network activity is differentially affected by amyloid beta peptides. Peptides 2010 31 9 1761 1766 2-s2.0-77955654861 10.1016/j.peptides.2010.06.003
54. Shin J., Theta rhythm heterogeneity in humans. Clinical Neurophysiology 2010 121 3 456 457 2-s2.0-75449086510 10.1016/j.clinph.2009.12.008
55. Shin J., Kim D., Bianchi R., Wong R. K. S., Shin H. S., Genetic dissection of theta rhythm heterogeneity in mice. Proceedings of the National Academy of Sciences of the United States of America 2005 102 50 18165 18170 2-s2.0-29144480496 10.1073/pnas.0505498102 (Pubitemid 41798519)
56. Nerelius C., Sandegren A., Sargsyan H., Raunak R., Leijonmarck H., Chatterjee U., Fisahn A., Imarisio S., Lomas D. A., Crowther D. C., Strömberg R., Johansson J.,Helix targeting reduces amyloid- β peptide toxicity. Proceedings of the National Academy of Sciences of the United States of America 2009 106 23 9191 9196 2-s2.0-67249117859 10.1073/pnas.0810364106
57. Peña-Ortega F., Solis-Cisneros A., Ordaz B., Balleza-Tapia H., López-Guerrero J. J., Amyloid beta 1-42 inhibits entorhinal cortex activity in the beta-gamma range: role of GSK-3. Current Alzheimer Research 2012 9 7 857 863
58. Wisor J. P., Edgar D. M., Yesavage J., Ryan H. S., Mccormick C. M., Lapustea N., Murphy G. M., Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission. Neuroscience 2005 131 2 375 385 2-s2.0-13544275103 10.1016/j.neuroscience.2004. 11.018 (Pubitemid 40222446)
59. Akay M., Wang K., Akay Y. M., Dragomir A., Wu J., Nonlinear dynamical analysis of carbachol induced hippocampal oscillations in mice. Acta Pharmacologica Sinica 2009 30 6 859 867 2-s2.0-67549150771 10.1038/aps.2009.66
60. Verret L., Mann E. O., Hang G. B., Barth A. M., Cobos I., Ho K., Devidze N., Masliah E., Kreitzer A. C., Mody I., Mucke L., Palop J. J., Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 2012 149 3 708 721
61. Hermann D., Both M., Ebert U., Gross G., Schoemaker H., Draguhn A., Wicke K., Nimmrich V., Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes. Neuroscience 2009 162 4 1081 1090 2-s2.0-67949104946 10.1016/j.neuroscience.2009.05.044
62. Cramer P. E., Cirrito J. R., Wesson D. W., Lee C. Y., Karlo J. C., Zinn A. E., Casali B. T., Restivo J. L., Goebel W. D., James M. J., Brunden K. R., Wilson D. A., Landreth G. E., ApoE-directed therapeutics rapidly clear β -amyloid and reverse deficits in AD mouse models. Science 2012 335 6075 1503 1506 10.1126/science.1217697
63. Wesson D. W., Borkowski A. H., Landreth G. E., Nixon R. A., Levy E., Wilson D. A., Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β -amyloidosis mouse model. Journal of Neuroscience 2011 31 44 15962 15971
64. Colom L. V., Septal networks: relevance to theta rhythm, epilepsy and Alzheimer's disease. Journal of Neurochemistry 2006 96 3 609 623 2-s2.0-33645105539 10.1111/j.1471-4159.2005.03630.x
65. Carrillo-Reid L., Tecuapetla F., Tapia D., Hernández-Cruz A., Galarraga E., Drucker-Colin R., Bargas J., Encoding network states by striatal cell assemblies. Journal of Neurophysiology 2008 99 3 1435 1450 2-s2.0-40949086768 10.1152/jn.01131.2007 (Pubitemid 351413721)
66. Leão R. N., Colom L. V., Borgius L., Kiehn O., Fisahn A., Medial septal dysfunction by A β -induced KCNQ channel-block in glutamatergic neurons. Neurobiology of Aging 2012 33 9 2046 2061
67. 2+ oscillations in cultured hippocampal networks. Cell Biology International 2006 30 9 733 740 2-s2.0-33748306219 10.1016/j.cellbi.2006.05.005 (Pubitemid 44331631)
68. Rönicke R., Mikhaylova M., Rönicke S., Meinhardt J., Schröder U. H., Fändrich M., Reiser G., Kreutz M. R., Reymann K. G., Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiology of Aging 2011 32 12 2219 2228
69. Santos S. F., Pierrot N., Morel N., Gailly P., Sindic C., Octave J. N., Expression of human amyloid precursor protein in rat cortical neurons inhibits calcium oscillations. Journal of Neuroscience 2009 29 15 4708 4718 2-s2.0-65549153713 10.1523/JNEUROSCI.4917-08.2009
70. Fuentealba J., Dibarrart A., Saez-Orellana F., Fuentes-Fuentes M. C., Oyanedel C. N., Guzmán J., Perez C., Becerra J., Aguayo L. G., Synaptic silencing and plasma membrane dyshomeostasis induced by amyloid- β peptide are prevented by Aristotelia chilensis enriched extract. Journal of Alzheimers Disease 2012 31 4 879 889 10.3233/JAD-2012-120229
71. Görtz P., Opatz J., Siebler M., Funke S. A., Willbold D., Lange-Asschenfeldt C., Transient reduction of spontaneous neuronal network activity by sublethal amyloid β (1-42) peptide concentrations. Journal of Neural Transmission 2009 116 3 351 355 2-s2.0-61849182002 10.1007/s00702-009- 0188-y
72. Palop J. J., Chin J., Roberson E. D., Wang J., Thwin M. T., Bien-Ly N., Yoo J., Ho K. O., Yu G. Q., Kreitzer A., Finkbeiner S., Noebels J. L., Mucke L., Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007 55 5 697 711 2-s2.0-34548264782 10.1016/j.neuron.2007.07.025 (Pubitemid 47321079)
73. Roberson E. D., Halabisky B., Yoo J. W., Yao J., Chin J., Yan F., Wu T., Hamto P., Devidze N., Yu G. Q., Palop J. J., Noebels J. L., Mucke L., Amyloid- β /fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of alzheimer's disease. Journal of Neuroscience 2011 31 2 700 711 2-s2.0-78651506630 10.1523/JNEUROSCI.4152-10.2011
74. Ziyatdinova S., Gurevicius K., Kutchiashvili N., Bolkvadze T., Nissinen J., Tanila H., Pitkänen A., Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels. Epilepsy Research 2011 94 1-2 75 85 2-s2.0-79952386386 10.1016/j.eplepsyres.2011.01.003
75. Gurevicius K., Lipponen A., Tanila H., Increased cortical and thalamic excitability in freely moving appswe/Ps1de9 mice modeling epileptic activity associated with Alzheimer's disease. Cerebral Cortex. In press
76. Brown J. T., Richardson J. C., Collingridge G. L., Randall A. D., Davies C. H., Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice. Hippocampus 2005 15 1 110 117 2-s2.0-14844334934 10.1002/hipo.20036 (Pubitemid 40340247)
77. Peña F., Tapia R., Relationships among seizures, extracellular amino acid changes, and neurodegeneration induced by 4-aminopyridine in rat hippocampus: a microdialysis and electroencephalographic study. Journal of Neurochemistry 1999 72 5 2006 2014 2-s2.0-0344026342 10.1046/j.1471-4159.1999. 0722006.x (Pubitemid 29186004)
78. Peña F., Alavez-Pérez N., Epileptiform activity induced by pharmacologic reduction of M-current in the developing hippocampus in vitro. Epilepsia 2006 47 1 47 54 2-s2.0-33645020074 10.1111/j.1528-1167.2006.00369.x
79. Peña F., Bargas J., Tapia R., Paired pulse facilitation is turned into paired pulse depression in hippocampal slices after epilepsy induced by 4-aminopyridine in vivo. Neuropharmacology 2002 42 6 807 812 2-s2.0-0036095009 10.1016/S0028-3908(02)00024-2 (Pubitemid 34518281)
80. Sepúlveda F. J., Opazo C., Aguayo L. G., Alzheimer β -amyloid blocks epileptiform activity in hippocampal neurons. Molecular and Cellular Neuroscience 2009 41 4 420 428 2-s2.0-67449102266 10.1016/j.mcn.2009.04.012
81. Sanchez P. E., Zhu L., Verret L., Vossel K. A., Orr A. G., Cirrito J. R., Devidze N., Ho K., Yu G. Q., Palop J. J., Mucke L., Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proceedings of the National Academy of Sciences of the United States of America 2012 109 42 2895 2903
82. Sanchez-Mejia R. O., Newman J. W., Toh S., Yu G. Q., Zhou Y., Halabisky B., Cissé M., Scearce-Levie K., Cheng I. H., Gan L., Palop J. J., Bonventre J. V., Mucke L., Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nature Neuroscience 2008 11 11 1311 1318 2-s2.0-54949130109 10.1038/nn.2213
83. Balleza-Tapia H., Peña F., Pharmacology of the intracellular pathways activated by amyloid beta protein. Mini-Reviews in Medicinal Chemistry 2009 9 6 724 740 2-s2.0-69249209789 10.2174/138955709788452784